Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PRTC
PRTC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRTC News
PureTech Announces Voluntary Delisting Plan
Apr 29 2026
seekingalpha
PureTech Health Reports 2025 Financial Results and Strategic Update
Apr 29 2026
Newsfilter
Seaport Therapeutics Appoints Dr. Sharon Mates to Board of Directors
Apr 27 2026
Newsfilter
Seaport Therapeutics Files for IPO to Develop Neuropsychiatric Drugs
Apr 11 2026
seekingalpha
Deupirfenidone Shows Significant Efficacy in Idiopathic Pulmonary Fibrosis
Apr 02 2026
Newsfilter
Seaport Therapeutics Announces Positive Clinical Data for GlyphAgo
Apr 02 2026
Newsfilter
Seaport Therapeutics Publishes GlyphAllo Clinical Data
Mar 25 2026
Newsfilter
PureTech Health to Participate in Healthcare Conference
Feb 25 2026
Businesswire
PureTech Secures Orphan Drug Designation for Deupirfenidone in IPF Treatment
Feb 19 2026
Businesswire
PureTech Secures Orphan Drug Designation for LYT-100, Advancing New Treatment Development
Feb 19 2026
Newsfilter
Robert Lyne Appointed CEO of PureTech
Dec 18 2025
Yahoo Finance
PureTech Appoints Robert Lyne as CEO, Focuses on Funding and Innovation
Dec 18 2025
Businesswire
PureTech Appoints Robert Lyne as CEO, Focuses on Funding and Innovation
Dec 18 2025
Newsfilter
Meihua International Medical Technologies, Fly-E Group, and Other Major Stocks Decline in Pre-Market Trading on Monday
Dec 08 2025
Benzinga
PureTech Completes FDA EOP2 Meeting, Advancing LYT-100 for IPF Treatment
Dec 08 2025
Businesswire
PureTech Advances LYT-100 into Phase 3 Clinical Trial Following FDA Feedback
Dec 08 2025
Newsfilter
Show More News
